genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Natural Products
Scorpion Toxin and Wasabi Receptors Help Scientists Unravel Chronic Pain Mechanisms
News
Piezo Proteins Findings Open New Paths in Understanding Their Role in…
GWAS
Ethnically Diverse GWAS Reveals New Child Obesity Locus
News
CRISPR Base Editing Gives Live Cell Computation an Upgrade
Pfizer
Pfizer Raises Gene Therapy Stake with $500M Sanford, NC, Expansion
Insights
Artificial Intelligence
Let There Be Sound: Turning Amino Acids into Tunes to Better…
Neuroscience
The Worm Gets a Wiring Diagram
On Your Radar
Set Phages to Kill
Insights
DNA Sequencing Accuracy Comes a Long Way
Insights
Top 10 Companies Leveraging Gene Editing in 2019
A-Lists
Insights
Top 10 Companies Leveraging Gene Editing in 2019
Insights
Top 10 Young Companies in the Money, January–July 2019
August 2019 Vol. 39 No. 8
Top 10 Biopharma IPOs of January–June 2019
Insights
Top 10 M&A Deals of January–June 2019
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Natural Products
Scorpion Toxin and Wasabi Receptors Help Scientists Unravel Chronic Pain Mechanisms
GWAS
Ethnically Diverse GWAS Reveals New Child Obesity Locus
News
CRISPR Base Editing Gives Live Cell Computation an Upgrade
Pfizer
Pfizer Raises Gene Therapy Stake with $500M Sanford, NC, Expansion
Magazine
All
Supplement
Tech Exclusives
Medical Cannabis Poses Unique Testing Challenges
Tech Exclusives
Single-Use Technology Has Biopharma Sizing Up the Recycling Bin
Microfluidics
Microfluidics Stands on the Shoulders of Microfab Giants
On Your Radar
A Finger on the Pulse of Genome Editing
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Improving Large Molecule Production Processes by Integrating Innovative Technology Solutions
August 2019 Vol. 39 No. 8
The OmniAb® Platform: Human Sequence Antibodies from Mouse, Rat and Chicken
August 2019 Vol. 39 No. 8
Cloud-Based Water Monitoring
Tech Exclusives
Oncology’s Fifth Pillar: Cellular Immunotherapy
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Therapeutics
Orphan Drugs
Orphan Drugs
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Orphan Drugs
Fetal Gene Therapy Prevents Fatal Form of Gaucher Disease
Orphan Drugs
United Therapeutics to Acquire SteadyMed for Up to $216M
Orphan Drugs
Novartis to Acquire Gene Therapy Developer AveXis for $8.7B
Orphan Drugs
PhaseBio Wins $2.8M SBIR Grant to Advance Lead Candidate
Orphan Drugs
Erytech, Queen’s Partner to Develop Red Blood Cell-Encapsulated Enzyme Therapy
Orphan Drugs
FDA Commits to Eliminating Orphan Drug Backlog by September
Orphan Drugs
FDA Approves CSL Behring’s Self-Administered C1 Esterase Inhibitor HAE Prophylactic
Orphan Drugs
TeneoBio, Selexis Sign SUREtechnology Cell-Line Agreement for Anticancer UniAbs
Orphan Drugs
Mithra’s E4 Estrogen Wins EU Orphan Drug Designation for Treating HIE...
Orphan Drugs
Start-Up Firm Palladio to Repurpose Lixivaptan as Treatment for PKD
Orphan Drugs
Shire Plans Lanadelumab BLA Submission Following Positive Phase III HAE Results
Orphan Drugs
Synlogic, Mirna Agree to Stock-Based Merger to Focus on Synthetic Biotic...
Orphan Drugs
Ionis Antisense Drug Meets Primary Endpoints in Phase III FAP Study
Orphan Drugs
EC Clears EUSA’s Dinutuximab Beta for High-Risk Neuroblastoma in Children
Orphan Drugs
Tasly, Pharnext Partner on Drug Combinations, Including Lead Phase III CMT1A...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
